
Looking for stable dividend stocks trading at a discount? Here are three that stand out.
Madhusudan Kela has picked stake in this stock. Do you own it?
Tapping into a high-growth sector, these lab-grown diamond stocks could be tomorrow’s portfolio winners. Are you watching close enough?
Three stocks have reported steady profit growth for four quarters. Valuations vary, but business momentum appears consistent across all three.
Gold has outperformed stocks in both short and long terms, proving fear-driven investing can be surprisingly profitable for Indian investors.
Here’s a comprehensive guide for investors on Canara Bank.
The latest survey by Marcellus Investment Managers, in collaboration with Dun & Bradstreet, on India’s ultra-HNIs uncovers a cautious investment…
Kiyosaki has warned that stock, bond, and real estate markets are all in trouble.
The stock hit an upper circuit, and for the month of May, it surged by 41.43 per cent. The rally…
Rekha Jhunjhunwala, ace investor and wife of the late Rakesh Jhunjhunwala, both need no introduction. They both can very well…
Kacholia and Agarwal, names that need no introduction in the investor circles of India. With hundreds of crores worth of…
While defense stocks have recently surged amid geopolitical tensions, Gujarat-based Banco Products India Ltd has quietly outshined them all, rallying…
Cement demand is booming, but are the top players truly ready? Uncover the strengths, risks, and real value behind India’s…
India’s alcohol sector is gaining from rising demand, premiumisation, and easing costs. Radico, United Spirits, and Tilaknagar are poised to…
While many investors are focussed on picking the next multibagger, they look at big names or known companies. Nothing wrong…
The UK-India trade deal could benefit textile exporters like Indo Count, KPR Mills, and Vardhman. But with high valuations, it’s…
In the current market scenario, buying stocks at lower valuations can provide margin of safety. Below are 4 such undervalued…
These undervalued agriculture stocks could offer strong long-term potential for patient investors.